Email: cspc@cspc.cn
Media
News Center
Aug. 29
2018
Passion and Persistence: A New Departure after Opdivo
“Over the years, my friends in China kept asking me when the anti-cancer drugs we develop will be available for Chinese patients. I am happy to be involved in developing novel and better drugs for them,”
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us